Fast Lab COO Pleaded Guilty in Fraud Case
Hasan Seyhun admitted to his role in a scheme that submitted over $500 million in fake healthcare claims.
Updated on Sept. 24, 2026 in Financial Crime
Live Poll
Should the government increase oversight of private medical labs receiving public healthcare funds?
Hasan Seyhun, the former Chief Operating Officer of Fast Lab Technologies, LLC, pleaded guilty to conspiracy to commit healthcare fraud. He orchestrated a scheme that resulted in at least $35 million in illicit government payments.
Why it matters
The scheme exploited government healthcare programs by billing for medical services that never occurred, including fraudulent COVID-19 testing claims. Participants were driven by the goal of personal financial gain through these systematic deceptions.
Hasan Seyhun officially entered his guilty plea in Detroit federal court on September 23, 2026. He has agreed to a forfeiture money judgment of $4,313,153 as part of the case proceedings.
The players
Hasan Seyhun
The 45-year-old former Chief Operating Officer of Fast Lab Technologies, LLC, who orchestrated a multimillion-dollar healthcare fraud scheme.
Fast Lab Technologies, LLC
A New York-based company that utilized online COVID-19 testing offers to facilitate large-scale insurance billing fraud.
Cemhan Biricik
An individual previously charged by federal authorities as a co-conspirator in the Fast Lab Technologies fraud scheme.
Martin Perlin
A co-conspirator previously charged alongside other Fast Lab executives for their involvement in the fraudulent billing operation.
The details
Fast Lab Technologies solicited customers online for no-cost COVID-19 tests, using their insurance information to bill for PCR, antigen, and saliva tests that were never performed. Claims were frequently submitted to government programs even before test kits were delivered to the customers.
Timeline
September 23, 2026: Hasan Seyhun entered a guilty plea in court.
April 7, 2026: The Department of Justice established the National Fraud Enforcement Division.
Legal Context
This case reflects the increasing federal scrutiny of medical billing schemes that emerged during the pandemic, mirroring a broader crackdown on healthcare fraud. The prosecution follows a pattern set by the Department of Justice, which recently launched the National Fraud Enforcement Division to address such sophisticated illicit activities.
The case highlights the importance of consumers monitoring their own insurance explanation of benefits statements to detect unauthorized claims for services they never received. Residents in Detroit and beyond should report any suspicious charges associated with medical testing kits to the appropriate government authorities.
The takeaway
This case underscores the need for constant vigilance regarding personal medical insurance data when interacting with online healthcare providers. Consumers should always verify the legitimacy of testing companies before providing sensitive information to ensure their data is not exploited for fraudulent billing.
Further reading
For more information on ongoing prosecutions, visit the Financial Crime section.
Live Poll
Should the government increase oversight of private medical labs receiving public healthcare funds?
